Pancreatic cancer cells may depend on a protein that helps them take in the fuel needed to grow. Researchers at the Francis ...
Just one thing first.If your whites of your eyes or skin are yellow, or your urine is as dark as black tea, please see a ...
Clinical Trials Arena on MSN
ESMO26: Clinical progress shifts a historically difficult pancreatic cancer landscape
Revolution Medicines’ impressive daraxonrasib data has spurred hope in the pancreatic cancer space.
These scans capture more than organs; they also reveal the body's fat and muscle levels, which may change as health ...
Despite being one of the deadliest cancers, pancreatic screening carries more risks than benefits for average-risk patients, ...
I was told at my health checkup that my triglycerides are high. How is that different from cholesterol?I hardly eat any sweets, yet my triglycerides are high every year. Why?Will my triglycerides go ...
Expanding on the unprecedented final results previously reported from the Phase 3 RASolute 302 trial, the exploratory subgroup analyses showed ...
Amplia Therapeutics has advanced its cancer drug narmafotinib across four trials, with data suggesting it may work independently of common tumour-causing KRAS gene mutations.
Five weeks after the FDA approved a pill that extends survival in metastatic pancreatic cancer, one of the physicians who led ...
Alcohol may contribute to pancreatic cancer risk more than some earlier studies suggested, according to a review of long-term ...
Experts say screening average-risk patients causes more harm than good, though high-risk individuals may benefit.
Pancreatic cancer cells are remarkably good at doing one thing: growing. But new Texas A&M research suggests that two tiny molecules already present in the body may help slow them down.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results